CJC-1295 No DAC 10mg (Modified GRF 1-29) – Research Peptide Overview

CJC-1295 No DAC 10mg, also known as Modified GRF 1-29, is a synthetic growth hormone–releasing hormone (GHRH) analog studied in peptide research, cellular signaling, and endocrine science.

CJC-1295 No DAC is researched for its role in understanding growth hormone pathways and receptor signaling. Unlike DAC-containing analogs, the No DAC version is commonly studied in models focused on shorter-duration signaling and pulsatile hormone pathway research.

Research Areas of Interest

GHRH Receptor Signaling

CJC-1295 No DAC is investigated for its interaction with GHRH receptors and related cellular communication pathways involved in hormone regulation.

Growth Hormone Pathway Research

Researchers study this peptide to better understand pituitary signaling, growth hormone release patterns, and endocrine system processes.

Metabolic & Cellular Research

CJC-1295 No DAC continues to be explored in research involving metabolism, cellular signaling, and biological pathways related to growth hormone activity.

Comparative Peptide Studies

Research may compare CJC-1295 No DAC with other GHRH analogs to examine differences in structure, stability, and signaling characteristics.

Product Details

Product Name: CJC-1295 No DAC
Alternative Name: Modified GRF 1-29
Category: Research Peptide / GHRH Analog
Form: Lyophilized powder
Size: 10mg

Biohacking Elite Quality Focus

Biohacking Elite provides research-focused products and educational resources for individuals interested in peptide science, longevity research, and biohacking innovation.

For research and educational purposes only. Not for human or veterinary use.